Please check your internet connection and try again.
# Lorazepam
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, anticonvulsant, and muscle relaxant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor.
## Primary Indications
* Management of anxiety disorders.
* Short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms.
* Insomnia, characterized by difficulty falling or staying asleep, or early awakening.
* Status epilepticus (IV/IM).
* Preoperative or preprocedural sedation.
## Adult Dosing
* **Anxiety:** 1 mg to 2 mg orally two to three times daily. Maximum daily dose: 10 mg.
* **Insomnia due to anxiety:** 1 mg to 2 mg orally at bedtime.
* **Status Epilepticus:** 4 mg IV/IM as a single dose. May repeat in 5 to 10 minutes if seizure persists. Maximum dose: 8 mg.
* **Preoperative Sedation:** 2 mg to 4 mg IM one to two hours prior to surgery.
* **Preprocedural Sedation:** 1 mg to 4 mg IV, IM, or PO, depending on the procedure and patient response.
## Pediatric Dosing
Dosing in pediatric patients is highly variable and should be determined by a clinician experienced in pediatric pharmacology.
* **Anxiety:** Generally not recommended for children under 12 years of age. For adolescents (12-18 years), initial doses may range from 0.5 mg to 2 mg orally divided into two or three doses.
* **Status Epilepticus:** 0.1 mg/kg IV/IM, not to exceed 4 mg per dose. May repeat in 5 to 10 minutes.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. No specific dose adjustment, but lower doses and slower titration may be necessary.
* **Renal Impairment:** No specific dose adjustment, but use with caution.
* **Elderly:** Lower doses are recommended due to increased sensitivity and potential for impaired metabolism and excretion. Initial dose of 1 mg to 2 mg orally daily, divided into doses.
## Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis.
* Sleep apnea.
## Adverse Effects
* **Common:** Sedation, drowsiness, dizziness, fatigue, unsteadiness, cognitive impairment, amnesia.
* **Less Common:** Paradoxical reactions (agitation, excitement, hallucinations), depression, ataxia, blurred vision, gastrointestinal upset, respiratory depression (especially with IV administration or in combination with other CNS depressants).
* **Serious:** Respiratory depression, dependence, withdrawal symptoms, suicidal ideation.
## Key Drug Interactions
* **CNS Depressants (opioids, alcohol, other sedatives, antipsychotics, antihistamines):** Additive CNS depressant effects, increased risk of sedation, respiratory depression, and death.
* **CYP3A4 Inhibitors/Inducers:** Lorazepam is metabolized by glucuronidation, not primarily by CYP enzymes, so interactions with CYP inhibitors or inducers are less common compared to other benzodiazepines. However, caution is advised.
* **Theophylline/Aminophylline:** May reduce the sedative effects of lorazepam.
## Monitoring
* Monitor for sedation, respiratory rate, blood pressure, and level of consciousness, especially with IV/IM administration.
* Assess for therapeutic response and presence of adverse effects.
* Monitor for signs of tolerance, dependence, and withdrawal, particularly with prolonged use.
## Clinical Pearls
* Lorazepam has a relatively long half-life, which can lead to accumulation, especially in the elderly or those with hepatic impairment.
* Intravenous lorazepam can cause propylene glycol toxicity if administered in high doses or for prolonged periods, particularly in patients with renal impairment.
* Abrupt discontinuation can lead to withdrawal symptoms, including rebound insomnia, anxiety, tremors, and, in severe cases, seizures. Tapering of the dose is recommended.
* Lorazepam is often the benzodiazepine of choice for status epilepticus due to its efficacy and relatively rapid onset of action when administered intravenously.
***
*This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions.*
